BlackRock Inc. - RXI PHARMACEUTICALS CORP NEW ownership

Back to all holdings Add to watchlist

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C808. A total of 15 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BlackRock Inc. ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q3 2018$1,000
-50.0%
1,1150.0%0.00%–
Q2 2018$2,000
-33.3%
1,1150.0%0.00%–
Q1 2018$3,000–1,115–0.00%–
 Download
Other shareholders

There were no reported owners of RXI PHARMACEUTICALS CORP NEW in Q2 2018.

NameSharesValueWeighting ↓
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders